跳至主要内容
临床试验/NL-OMON41634
NL-OMON41634招募中3 期

ACNS0332: Efficacy of Carboplatin Administered Concomitantly With Radiation and Isotretinoin as a Pro-Apoptotic Agent in Other Than Average Risk Medulloblastoma/PNET Patients - A Groupwide Phase III Study - Carboplatin and isotretinoin for children with high risk medulloblastoma

Stichting Kinderoncologie Nederland0 个研究点目标入组 21 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
21

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
2 至 99(—)

入选标准

  • Age greater or equal to 3 y and less than 22 y at time of diagnosis
  • Newly diagnosed previously untreated medulloblastoma (M0 with >1.5 cm2 residual, or M1-3); (amendment 2: inclusion sPNET discontinued)
  • Written informed consent (parents and patient)

排除标准

  • Age less than 3 y
  • Extraneural metastases
  • Karnofski/Lansky < 50% and life expectancy <= 8 weeks
  • Inadequate organ function prior to start of therapy (renal, liver, bonemarrow)
  • Previous chemotherapy or radiation therapy
  • Other experimental therapy

研究者

发起方
Stichting Kinderoncologie Nederland

相似试验

招募中
1 期
A phase I/II study of carboplatin in combination with nab-paclitaxel and thoracic radiation in elderly patients with previously untreated non-small cell lung cancerocally Advanced Non-Small Cell Lung Cancer
JPRN-UMIN000016730Foundation for Biomedical Research and Innovation43
未知
2 期
Phase II study in combination with Carboplatin and TS-1 for Cancer of unknown primaryCancer of unknown primary
JPRN-UMIN000001236ational Cancer Center Hospital, Tokyo35
进行中(未招募)
1 期
Veliparib in combination with carboplatin and paclitaxel and as continuation maintenance therapy in subjects with newly diagnosed, untreated Stage III or IV high-grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancerewly diagnosed, untreated Stage III or IV high-grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer
EUCTR2014-005070-11-PLAbbVie Deutschland GmbH & Co. KG1,100
进行中(未招募)
1 期
Veliparib in combination with carboplatin and paclitaxel and as continuation maintenance therapy in subjects with newly diagnosed, untreated Stage III or IV high-grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer
EUCTR2014-005070-11-DKAbbVie Deutschland GmbH & Co. KG1,100
进行中(未招募)
1 期
Veliparib in combination with carboplatin and paclitaxel and as continuation maintenance therapy in subjects with newly diagnosed, untreated Stage III or IV high-grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancerewly diagnosed, untreated Stage III or IV high-grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer
EUCTR2014-005070-11-ESAbbVie Deutschland GmbH & Co. KG1,100